The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...
Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.
February 14, 2025 – IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, yesterday presented Phase 1 data on its allogeneic gamma ...
The BC Cancer Foundation has launched a $6.8 million fundraising campaign to expand provincial immunotherapy research program ...
IN8bio (INAB) presented Phase 1 data on its allogeneic gamma-delta T cell therapy, INB-100, at the 2025 Transplantation & Cellular Therapy, ...
During a Case-Based Roundtable® event, Nitin Jain, MD, and participants discussed treating a patient with CLL after ...
US FDA grants fast track designation to NKGen Biotech’s natural killer cell therapy, troculeucel to treat moderate Alzheimer’s disease: Santa Ana, California Saturday, Februar ...
Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.
Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...
Just Like Magic dropped a strong hint he could win a race when third at 14-1 at Wolverhampton last month, and the son of ...
KIRO Seattle on MSN12h
City of Seattle will now cover former firefighter’s treatment for cancer caused by jobI think the biggest tragedy in all of this is standing by on a billing code and refusing to be human and even reach out to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback